Chargement en cours...
ICS-formoterol reliever versus ICS and short-acting β(2)-agonist reliever in asthma: a systematic review and meta-analysis
BACKGROUND: The Global Initiative for Asthma recommends as-needed inhaled corticosteroid (ICS)-formoterol as an alternative to maintenance ICS plus short-acting β(2)-agonist (SABA) reliever at step 2 of its stepwise treatment algorithm. Our aim was to assess the efficacy and safety of these two trea...
Enregistré dans:
| Publié dans: | ERJ Open Res |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
European Respiratory Society
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836558/ https://ncbi.nlm.nih.gov/pubmed/33532465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00701-2020 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|